U04 Severe acute respiratory syndrome [SARS]

U04.9 Severe acute respiratory syndrome [SARS], unspecified

NCCS

DCS.XXII.1

U06 Emergency use of U06

NCCS

DCS.XXII.3

Note:

Codes U00-U49 are to be used by WHO for the provisional assignment of new diseases of uncertain etiology. In emergency situations codes are not always accessible in electronic systems. The specification of category U06 in the way it is done here will make sure this category and the subcategories are available in every electronic system at any time and that they can be used upon instruction by WHO, immediately.

U06.0 Emergency use of U06.0

U06.1 Emergency use of U06.1

U06.2 Emergency use of U06.2

U06.3 Emergency use of U06.3

U06.4 Emergency use of U06.4

U06.5 Emergency use of U06.5

U06.6 Emergency use of U06.6

U06.7 Emergency use of U06.7

U06.8 Emergency use of U06.8

U06.9 Zika virus disease

NCCS

DCS.I.5

U07 Emergency use of U07

NCCS

DCS.XXII.3

Note:

Codes U00-U49 are to be used by WHO for the provisional assignment of new diseases of uncertain etiology. In emergency situations codes are not always accessible in electronic systems. The specification of category U07 in the way it is done here will make sure this category and the subcategories are available in every electronic system at any time and that they can be used upon instruction by WHO, immediately.

U07.0 Vaping-related disorder

NCCS

DCS.XXII.4 Guidance

U07.1 COVID-19, virus identified

NCCS

DCS.XXII.6 DCS.XXII.8 DCS.XXII.13

COVID-19 NOS

Use this code when COVID-19 has been confirmed by laboratory testing irrespective of severity of clinical signs or symptoms. Use additional code, if desired, to identify pneumonia or other manifestations.

Excl.:

Coronavirus infection, unspecified site ( B34.2)

Coronavirus as the cause of diseases classified to other chapters ( B97.2)

Severe acute respiratory syndrome [SARS], unspecified( U04.9)

U07.2 COVID-19, virus not identified

NCCS

DCS.XXII.7 DCS.XXII.8 DCS.XXII.13

Use this code when COVID-19 is diagnosed clinically or epidemiologically but laboratory testing is inconclusive or not available. Use additional code, if desired, to identify pneumonia or other manifestations

Excl.:

Coronavirus infection, unspecified site ( B34.2)

COVID-19:

• confirmed by laboratory testing (U07.1)
• special screening examination (Z11.5)
• suspected but ruled out by negative laboratory results (Z03.8)

U07.3 Personal history of COVID-19

NCCS

DCS.XXII.9

Note:

This optional code is used to record an earlier episode of COVID-19, confirmed or probable, that influences the person’s health status, and the person no longer suffers from COVID-19. This code should not be used for primary mortality tabulation.

U07.4 Post COVID-19 condition

NCCS

DCS.XXII.10

Note:

This optional code serves to allow the establishment of a link with COVID-19. This code is not to be used in cases that still are presenting COVID-19.

U07.5 Multisystem inflammatory syndrome associated with COVID-19

NCCS

DCS.XXII.11

Excl.:

Mucocutaneous lymph node syndrome [Kawasaki] ( M30.3)

U07.6 Need for immunization against COVID-19

NCCS

DCS.XXII.12

Note:

This code should not be used for international comparison or for primary mortality coding. This optional code is intended to be used when a person who may or may not be sick encounters health services for the specific purpose of receiving a COVID-19 vaccine.

Prophylactic COVID-19 vaccination

Excl.:

immunization not carried out ( Z28.-)

U07.7 COVID-19 vaccines causing adverse effects in therapeutic use

NCCS

DCS.XXII.12

Note:

This code is to be used as an external cause code (i.e. as a subcategory under Y59 Other and unspecified vaccines and biological substances). In addition to this, a code from another chapter of the classification should be used indicating the nature of the adverse effect.

Correct administration of COVID-19 vaccine in prophylactic therapeutic use as the cause of any adverse effect.

U07.8 Emergency use of U07.8

U07.9 Emergency use of U07.9